Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Webster, R.
Right arrow Articles by Beeson, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Webster, R.
Right arrow Articles by Beeson, D.
Related Collections
Right arrow Amyotrophic lateral sclerosis
Right arrow Ion channel gene defects
NEUROLOGY 2004;62:1090-1096
© 2004 American Academy of Neurology

Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome

R. Webster, PhD, M. Brydson, BSc, R. Croxen, DPhil, J. Newsom–Davis, MD, A. Vincent, FRCPath and D. Beeson, PhD

From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.

Address correspondence and reprint requests to Dr. D. Beeson, Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, OX3 9DS, UK; e-mail: dbeeson{at}hammer.imm.ox.ac.uk

Background: Most congenital myasthenic syndromes (CMS) have postsynaptic defects from mutations within the muscle acetylcholine receptor (AChR). Mutations underlying the slow channel syndrome cause a "gain of function" and usually show dominant inheritance, whereas mutations underlying AChR deficiency or the fast channel syndrome cause a "loss of function" and show recessive inheritance.

Objective: To characterize the disease mechanism underlying an apparently dominantly inherited CMS that responds to IV edrophonium.

Methods: DNA from CMS patients was analyzed for mutations by single-strand conformation polymorphism analysis, DNA sequence analysis, and restriction endonuclease digestion. Functional analysis of mutations was by {alpha}-bungarotoxin binding studies and by patch clamp analysis of mutant AChR expressed in human embryonic kidney cells.

Results: Analysis of muscle biopsies from father and son in an affected kinship showed normal endplate morphology and AChR number but severely reduced miniature endplate potentials. DNA analysis revealed that each harbors a single missense mutation in the AChR {alpha}-subunit gene, {alpha}F256L. Expression studies demonstrate this mutation underlies a fast channel phenotype with fewer and shorter ion channel activations. The major effect of {alpha}F256L, located within the M2 transmembrane domain, is on channel gating, both reducing the opening and increasing the closure rate.

Conclusions: Mutation {alpha}F256L results in fast channel kinetics. Expression studies suggest a dominant-negative effect within the AChR pentamer, severely compromising receptor function.


Received June 27, 2003. Accepted in final form November 26, 2003.




This article has been cited by other articles:


Home page
JWatch NeurologyHome page
Congenital Myasthenic Syndrome: A Mutation That Goes Against the Rules
Journal Watch Neurology, July 9, 2004; 2004(709): 4 - 4.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.